164 related articles for article (PubMed ID: 19449674)
1. Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.
Pelavin PI; Abramson E; Pon S; Vogiatzi MG
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):171-5. PubMed ID: 19449674
[TBL] [Abstract][Full Text] [Related]
2. Pediatric glipizide ingestion, onset of hypoglycemia, and octreotide.
Osterhoudt KC; Calello DP
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1185. PubMed ID: 20333881
[No Abstract] [Full Text] [Related]
3. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
Carr R; Zed PJ
Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
[TBL] [Abstract][Full Text] [Related]
4. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
Nzerue CM; Thomas J; Volcy J; Edeki T
Int J Artif Organs; 2003 Jan; 26(1):86-9. PubMed ID: 12602474
[TBL] [Abstract][Full Text] [Related]
5. Octreotide for the treatment of sulfonylurea poisoning.
Glatstein M; Scolnik D; Bentur Y
Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
[TBL] [Abstract][Full Text] [Related]
6. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler.
Llamado R; Czaja A; Stence N; Davidson J
J Emerg Med; 2013 Dec; 45(6):e209-13. PubMed ID: 23827165
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea Poisoning in a Healthy Toddler.
Kumar S; Choudhary A; Ali M; Gupta V; Muralidharan J; Singhi SC
Indian J Pediatr; 2017 Feb; 84(2):147-149. PubMed ID: 27796819
[TBL] [Abstract][Full Text] [Related]
8. Octreotide's role in the management of sulfonylurea-induced hypoglycemia.
Dougherty PP; Klein-Schwartz W
J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540
[TBL] [Abstract][Full Text] [Related]
9. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
Groth CM; Banzon ER
J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
[TBL] [Abstract][Full Text] [Related]
10. Refractory Hypoglycemia Due to Sulfonylurea Contamination of Illicit Opioid Medications.
Savarino JR; Mokszycki R; Tubbs R; Wightman RS
R I Med J (2013); 2024 May; 107(5):11-13. PubMed ID: 38687261
[TBL] [Abstract][Full Text] [Related]
11. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
Boyle PJ; Justice K; Krentz AJ; Nagy RJ; Schade DS
J Clin Endocrinol Metab; 1993 Mar; 76(3):752-6. PubMed ID: 8445035
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
Graudins A; Linden CH; Ferm RP
Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
[No Abstract] [Full Text] [Related]
13. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
Vallurupalli S
Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicenter study of sulfonylurea ingestion in children.
Spiller HA; Villalobos D; Krenzelok EP; Anderson BD; Gorman SE; Rose SR; Fenn J; Anderson DL; Muir SJ; Rodgers GC
J Pediatr; 1997 Jul; 131(1 Pt 1):141-6. PubMed ID: 9255206
[TBL] [Abstract][Full Text] [Related]
15. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
16. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
[TBL] [Abstract][Full Text] [Related]
17. Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose.
Hassan Z; Wright J
Emerg Med J; 2007 Aug; 24(8):580-1. PubMed ID: 17652687
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose.
Gul M; Cander B; Girisgin S; Ayan M; Kocak S; Unlu A
Adv Ther; 2006; 23(6):878-84. PubMed ID: 17276956
[TBL] [Abstract][Full Text] [Related]
19. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
Lheureux PE; Zahir S; Penaloza A; Gris M
Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
[TBL] [Abstract][Full Text] [Related]
20. Octreotide therapy for nateglinide-induced hypoglycemia.
Sherk DK; Bryant SM
Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
